Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Sorafenib in radioactive iodine-refractory, locally advan... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
0
Authors
Marcia Brose
18 more
Marcia Brose
•
Christopher Nutting
16 more
•
Martin Schlumberger
Published
April 24, 2014
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Physics
Cancer Oncology
Medicine
Pathology
Internal Medicine
Show all topics
DOI
10.1016/s0140-6736(14)60421-9
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Physics
Cancer Oncology
Medicine
Pathology
Internal Medicine
Show all topics
DOI
10.1016/s0140-6736(14)60421-9
Other Formats
PDF